Systematic Financial Management LP Corcept Therapeutics Inc Transaction History

Systematic Financial Management LP

  • $3.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$12.46 - $19.98 $219,420 - $351,847
-17,610 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$11.0 - $18.26 $201,080 - $333,792
-18,280 Reduced 50.93%
17,610 $296,000
Q1 2020

May 12, 2020
SELL
$10.11 - $14.04 $101,403 - $140,821
-10,030 Reduced 21.84%
35,890 $427,000
Q4 2019

Feb 14, 2020
BUY
$12.06 - $16.96 $553,795 - $778,803
45,920 New
45,920 $556,000

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.3B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Systematic Financial Management LP Portfolio

Follow Systematic Financial Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email